Welcome to Miami, OpenEvidence.
OpenEvidence, considered one of the country’s hottest AI startups in healthcare, was founded in Cambridge, Mass. But by the time the company announced this week that it had raised another $200 million, the company had already moved to Miami, according to the Boston Globe and confirmed by State of Florida records.
The Globe reported that founder and CEO Daniel Nadler confirmed his company’s recent move to Miami but wouldn’t comment on why. Refresh Miami has also reached out. Nadler also reportedly bought a $38 million beachside condo in Miami this summer.
OpenEvidence, founded on the idea of helping medical professionals more quickly reach diagnoses, is the fastest-growing clinical decision support platform in the United States, and the most widely used medical search engine among U.S. clinicians, according to the company.
The company was founded in 2022 by Nadler and CTO Zachary Ziegler. Nadler previously founded an AI startup that was sold to S&P Global for $550 million. OpenEvidence has grown to become a highly popular tool among doctors, nurses and other medical practitioners and now supports about 15 million clinical consultations a month, Nadler told the New York Times, which first reported the fundraising news.
OpenEvidence’s chatbot is reportedly trained on medical journals from JAMA and the New England Journal of Medicine to help users quickly draw on existing medical knowledge to treat patients. The tool is free to use for verified medical professionals and is supported by advertising. It is used by more than 10,000 medical centers, Nadler said.
Daniel Nadler, founder and CEO of OpenEvidence
The $200 million Series C round on a $6 billion valuation came together in just a matter of days, the New York Times reported this week. After a presentation with Google that drew the attention of ad buyers, Google Ventures raised the idea of a new fund-raising round with Nadler on a Thursday; ironed out most details by Sunday and signed deal documents just days later, leading the Series C round. Other investors in the round included Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, BOND and Craft.
OpenEvidence also raised a $210 million Series B round in July, also led by Google Ventures, bringing the company’s funding total to about $500 billion in funding.
Google Ventures General Partner Sangreen Zeb, posted on LinkedIn: “Yesterday was the 10th anniversary of my little brother Amir’s death. He was only 30. During his health struggles, I met so many clinicians who were understaffed, sometimes very early in their careers, and always overworked. It’s Daniel Nadler’s hope, and mine, that OpenEvidence’s immensely powerful AI platform can help unburden these dedicated healthcare professionals so they can continue to provide the best care to their patients.”
READ MORE IN REFRESH MIAMI:
I am a writer and editor with extensive media experience and a passion for journalism and serving the community. Most of my career has been spent with the Miami Herald in business news, and my expertise is writing about tech and entrepreneurs. I love hosting this blog for Refresh Miami and we aim to be the go-to site for South Florida startup and tech news, features and views. Have news? Contact me at [email protected]. Thanks for reading! Latest posts by Nancy Dahlberg (see all)